Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[An overview of environmental pharmacoepidemiology].

Created on 20 Aug 2026

Authors

Z S Fu, Q Chen, Y Deng, S F Wang

Published in

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. Volume 47. Issue 8. Pages 1520-1526. Aug 10, 2026.

Abstract

Environmental pharmacoepidemiology (EPE) is an emerging interdisciplinary field developed to address the health challenges arising from the complex interactions between environmental factors and drug effects. This paper systematically introduces the definitions, core research domains, methodological framework, and public health significance of EPE. The field's primary objective is to integrate data on environmental exposures and drug utilization to evaluate how the environment influences the efficacy and safety of pharmaceuticals, as well as the potential impacts of drugs on the environment. By leveraging exposomics, phenome-wide data, and real-world big data, while applying advanced statistical methods like propensity scores and multilevel models, EPE facilitates a deeper investigation into the intricate "environment-drug-health" nexus. While facing challenges such as dynamic exposure assessment, poorly understood interaction mechanisms, and statistical modeling limitations, future advancements in EPE will provide crucial scientific support for achieving precision medicine and advancing the synergistic governance of environmental health.

PMID:
42618490
Bibliographic data and abstract were imported from PubMed on 20 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 14
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement